Olomoucine II

Mfr.No.	T35696
Description	Olomoucine II is an inhibitor of cyclin-dependent kinases (CDKs; IC50s = 7.6, 0.1, 19.8, 0.45, and 0.06 uM for Cdk1, -2, -4, -7, and -9, respectively).1It is selective for CDKs over 10 additional kinases (IC50s = >100 uM for all) but does inhibit ERK2 (IC50= 32 uM) and the ATP-binding cassette transporter B1 (ABCB1; IC50= 6.4 uM).1,2Olomoucine II inhibits proliferation of a variety of cancer cells, including those expressing wild-type p53 or mutant p53 (mean IC50s = 7.4 and 10.1 uM, respectively), and it acts synergistically with daunorubicin to inhibit proliferation of HCT-8 cells that endogenously express ABCB1. Olomoucine also inhibits replication of herpes simplex virus 1 (HSV-1), HSV-2, vaccinia virus, human adenovirus type 4 (Ad4), and human CMV (IC50s = 5, 4.7, 3.8, 2.4, and 3.2 uM, respectively) but not measles virus or influenza virus (IC50s = >20 uM for both).3
Molecular Formula	C19H26N6O2
Signaling Pathways	Others
Smiles	C(C)(C)N1C=2C(=C(NCC3=C(O)C=CC=C3)N=C(N(CH)(CC)CO)N2)N=C1
Cas Number	500735-47-7
Molecular Weight	370.45
Target	Others

Have you used this product?

SKU	Supplier No.	Size	Your price	Quantity
BHB20425104	T35696	1 mg	$110		Add to Cart